Author
The University of Texas MD Anderson Cancer CenterORCID 0000-0001-7219-5562Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Haopeng Yang, Kotaro Arita, Kevin Bowman…·Michael R. Green
The paper establishes a PDX repository of large B-cell lymphoma models capturing clinical and molecular diversity, including post-CART19 progression cases.
Patrick Kevin Reville, Irtiza N. Sheikh, Ahyun Choi…·Michael Green
The paper identifies dysfunctional CD8 CAR T-cells in rrLBCL tumors and shows that pegenzileukin mitigates this dysfunction, improving CAR T-cell responses.
Neeraj Y. Saini, David M. Swoboda, Uri Greenbaum…·Koichi Takahashi
This study finds that clonal hematopoiesis mutations, particularly in DNMT3A, TET2, and ASXL1, are linked to increased toxicity in patients undergoing anti-CD19 CAR T-cell therapy for large B-cell lymphoma.